AB

Aditum Bio

North America, California, United States, San Francisco

Description

Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.

Investor Profile

Aditum Bio has made 4 investments, with 2 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (50%)
  • Pre Seed (25%)
  • Series B (25%)

Country Focus

  • United States (75%)
  • United Arab Emirates (25%)

Industry Focus

  • Biotechnology
  • Life Science
  • Generative Ai
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aditum Bio frequently co-invest with?

Co-Investments: 1
Medicxi
Europe, England, United Kingdom, London
Co-Investments: 1
Phaze Ventures
Asia, Masqat, Oman, Muscat
Co-Investments: 1
DH
North America, California, United States, Beverly Hills
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 1
Jabbar Internet Group
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
Wamda Capital
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
10x Founders
Europe, Bayern, Germany, Munich
Co-Investments: 1

What are some of recent deals done by Aditum Bio?

Tempero Bio

Oakland, California, United States

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

BiopharmaBiotechnologyManufacturing
Series BMar 24, 2025
Amount Raised: $70,000,000
qeen.ai

Dubai, Dubai, United Arab Emirates

qeen.ai is a GenAI native platform that enables autonomous AI to e-commerce firms of all sizes.

Generative AI
Pre SeedJun 5, 2024
Amount Raised: $2,200,000
Via Nova Therapeutics

Oakland, California, United States

Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.

BiotechnologyLife ScienceTherapeutics
Series ASep 7, 2021
Amount Raised: $20,000,000
Versanis Bio

Oakland, California, United States

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

BiotechnologyLife ScienceMedicalPharmaceutical
Series AAug 31, 2021
Amount Raised: $70,000,000